CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions Association of Left Ventricular Systolic Function With Incident Heart Failure in Late Life Readmission and Mortality After Hospitalization for Myocardial Infarction and Heart Failure Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction Dilated cardiomyopathy: so many cardiomyopathies! Outcomes and Effect of Treatment According to Etiology in HFrEF An Analysis of PARADIGM-HF Mechanical circulatory support devices in advanced heart failure: 2020 and beyond

Original Research16 Sep 2019

JOURNAL:Circulation. Article Link

Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial

Nassif ME, Windsor S, DEFINE-HF Investigators. Keywords: SGLT-2 inhibitors; HFrEF; T2DM; Dapagliflozin effect

FULL TEXT PDF